These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35072430)

  • 21. Effect of initial empiric antibiotic therapy combined with control of the infection focus on the prognosis of patients with secondary peritonitis.
    Membrilla-Fernández E; Sancho-Insenser JJ; Girvent-Montllor M; Álvarez-Lerma F; Sitges-Serra A;
    Surg Infect (Larchmt); 2014 Dec; 15(6):806-14. PubMed ID: 25397738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial Peritonitis.
    Kim SW; Yoon JS; Park J; Jung YJ; Lee JS; Song J; Lee HA; Seo YS; Lee M; Park JM; Choi DH; Kim MY; Kang SH; Yang JM; Song DS; Chung SW; Kim MA; Jang HJ; Oh H; Lee CH; Lee YB; Cho EJ; Yu SJ; Kim YJ; Yoon JH; Lee JH
    Clin Gastroenterol Hepatol; 2021 May; 19(5):976-986.e5. PubMed ID: 32623007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of carbapenems in the treatment of serious infections.
    Baughman RP
    J Intensive Care Med; 2009; 24(4):230-41. PubMed ID: 19617229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opportunities to Improve Antibiotic Appropriateness in U.S. ICUs: A Multicenter Evaluation.
    Trivedi KK; Bartash R; Letourneau AR; Abbo L; Fleisher J; Gagliardo C; Kelley S; Nori P; Rieg GK; Silver P; Srinivasan A; Vargas J; Ostrowsky B;
    Crit Care Med; 2020 Jul; 48(7):968-976. PubMed ID: 32317600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nationwide survey of intravenous antimicrobial use in intensive care units in Japan.
    Ohnuma T; Hayashi Y; Yamashita K; Marquess J; Lefor AK; Sanui M;
    Int J Antimicrob Agents; 2018 Apr; 51(4):636-641. PubMed ID: 29408737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for acquisition of carbapenem-resistance during treatment with carbapenem in the intensive care unit: a prospective study.
    Labaste F; Grossac J; Bounes FV; Conil JM; Ruiz S; Seguin T; Grare M; Fourcade O; Minville V; Georges B
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2077-2085. PubMed ID: 31482416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spread of Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit: A Whole-Genome Sequence-Based Prospective Observational Study.
    Wei L; Wu L; Wen H; Feng Y; Zhu S; Liu Y; Tang L; Doughty E; van Schaik W; McNally A; Zong Z
    Microbiol Spectr; 2021 Sep; 9(1):e0005821. PubMed ID: 34259540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Educational ICU Antimicrobial Stewardship model: the daily activities of the AMS team over a 10-month period.
    Cappanera S; Tiri B; Priante G; Sensi E; Scarcella M; Bolli L; Costantini M; Andreani P; Sodo S; Martella LA; Francisci D
    Infez Med; 2019 Sep; 27(3):251-257. PubMed ID: 31545768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
    Vardakas KZ; Matthaiou DK; Falagas ME; Antypa E; Koteli A; Antoniadou E
    J Infect; 2015 Jun; 70(6):592-9. PubMed ID: 25447713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 31. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.
    Vallés J; Rello J; Ochagavía A; Garnacho J; Alcalá MA
    Chest; 2003 May; 123(5):1615-24. PubMed ID: 12740282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ignorance of pre-ED healthcare setting is a factor leading to inappropriate initial antibiotic treatment of sepsis in ED and poor outcomes in ICU.
    Su WL; Shui HA; Peng MY
    J Microbiol Immunol Infect; 2020 Aug; 53(4):532-541. PubMed ID: 31917133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU.
    Abdallah M; Badawi M; Amirah MF; Rasheed A; Mady AF; Alodat M; Alharthy A
    J Antimicrob Chemother; 2017 Nov; 72(11):3187-3190. PubMed ID: 28961733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.
    Colardyn F
    Acta Clin Belg; 2005; 60(2):51-62. PubMed ID: 16082989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A contemporary situation in the antimicrobial treatment of the secondary peritonitis].
    Vyhnánek F; Vranková J
    Rozhl Chir; 2005 Sep; 84(9):466-71. PubMed ID: 16250620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin.
    Scawn N; Saul D; Pathak D; Matata B; Kemp I; Stables R; Lane S; Haycox A; Houten R
    Health Technol Assess; 2012 Sep; 16(36):i-xiii, 1-70. PubMed ID: 23010339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis.
    Sotto A; Lefrant JY; Fabbro-Peray P; Muller L; Tafuri J; Navarro F; Prudhomme M; De La Coussaye JE
    J Antimicrob Chemother; 2002 Oct; 50(4):569-76. PubMed ID: 12356803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic prescription in intensive care units in Latin America.
    Curcio DJ;
    Rev Argent Microbiol; 2011; 43(3):203-11. PubMed ID: 22430995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.